To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MIB1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
435 supporting clones for gene MIB1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AY147849   .a 1 to 7426 16 to 7458 A2R A3R S4L E5P Q6N ... tiling clone,   7443/7458
(99 %)
17 diff
(99.8 %id)
DR002313 fetal brain .a 23 to 649 8 to 634   tiling clone,   627/634
(98 %)
5 diff
(99.3 %id)
CT000163 T-Lymphocytes .a 231 to 1007 1 to 777       777/782
(99 %)
1 diff
(99.9 %id)
AY149908   .a 255 to 3275 1 to 3021       3021/3021
(100 %)
0 diff
(100 %id)
BC110581 PCR rescued clones .a 255 to 3275 1 to 3021       3021/3021
(100 %)
0 diff
(100 %id)
BC110582 PCR rescued clones .a 255 to 3275 1 to 3021       3021/3021
(100 %)
0 diff
(100 %id)
NM_020774.2   .a 255 to 9562 1 to 9308   RefSeq,   9308/9308
(100 %)
0 diff
(100 %id)
BU165483 eye, retinoblastoma .a 276 to 1090 1 to 828       828/876
(94 %)
27 diff
(97.0 %id)
AK091266 tongue, tumor tissue .a 570 to 4003 1 to 3434   tiling clone, available from FLJ,   3434/3434
(100 %)
1 diff
(100.0 %id)
AX746883   .a 570 to 4003 1 to 3434       3434/3434
(100 %)
1 diff
(100.0 %id)
DA447081 tongue, tumor tissue .a 571 to 1102 2 to 534   capped   533/533
(100 %)
2 diff
(99.7 %id)
DA509935 brain .a 689 to 1245 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
BG200021   .a 782 to 1499 1 to 720       720/786
(91 %)
28 diff
(96.5 %id)
BG461418   .a 783 to 1489 1 to 707       707/778
(90 %)
64 diff
(91.8 %id)
DN989701 brain, whole brain .a 793 to 1351 11 to 569       559/569
(98 %)
6 diff
(99.0 %id)
CR749635 endometrium carcinoma cell line .a 835 to 8525 1 to 7703   available from DKFZ, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 7703/7703
(100 %)
10 diff
(99.9 %id)
CN282662 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1065 to 1784 1 to 722       722/722
(100 %)
3 diff
(99.6 %id)
DA196941 amygdala .a 1112 to 1616 2 to 506   capped   505/505
(100 %)
0 diff
(100 %id)
BM903940 eye, retinoblastoma .a 1130 to 2077 1 to 961       961/969
(99 %)
22 diff
(97.8 %id)
BC022403 lung .a 1879 to 3961 1 to 2083   available from MGC, AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 2083/2083
(100 %)
0 diff
(100 %id)
AB037744 brain .a 2084 to 7426 1 to 5356   available from KIAA,   5356/5356
(100 %)
7 diff
(99.9 %id)
AK075157 placenta .a 2133 to 4001 1 to 1871   available from FLJ,   1871/1871
(100 %)
2 diff
(99.9 %id)
DA830754 placenta .a 2134 to 2747 2 to 619   capped   618/622
(99 %)
12 diff
(98.1 %id)
AL713705 amygdala .a 2571 to 4524 1 to 1954   available from DKFZ, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 1954/1954
(100 %)
0 diff
(100 %id)
BU508025 leiomyosarcoma, uterus .a 3002 to 3983 1 to 999       999/1082
(92 %)
29 diff
(97.4 %id)
AL702202 human skeletal muscle .a 3012 to 3587 1 to 576       576/583
(98 %)
3 diff
(99.5 %id)
AK027338 whole embryo, mainly head .a 3073 to 4514 1 to 1442   available from FLJ,   1442/1442
(100 %)
2 diff
(99.9 %id)
DA571401 whole embryo, mainly head .a 3074 to 3883 2 to 810   capped   809/809
(100 %)
4 diff
(99.6 %id)
BG189823   .a 3098 to 3703 617 to 14     Submitted on the opposite strand 604/862
(70 %)
3 diff
(99.7 %id)
BU181582 eye, retinoblastoma .a 3219 to 4098 1 to 882       882/882
(100 %)
9 diff
(99.0 %id)
BG535465 lung .a 3251 to 3838 1 to 587       587/587
(100 %)
2 diff
(99.7 %id)
N44566 melanocyte .a 3254 to 3455 1 to 202       202/202
(100 %)
0 diff
(100 %id)
BM825127 Ascites, stomach .a 3279 to 3901 1 to 623       623/623
(100 %)
0 diff
(100 %id)
BE889259 leiomyosarcoma, uterus .a 3352 to 3968 1 to 617       617/892
(69 %)
10 diff
(98.9 %id)
DB314032 tongue, tumor tissue .a 3474 to 4003 530 to 1       530/532
(99 %)
2 diff
(99.7 %id)
AI160081 heart .a 3480 to 3961 482 to 1       482/482
(100 %)
0 diff
(100 %id)
BF515826   .a 3481 to 3961 496 to 16   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 481/481
(100 %)
0 diff
(100 %id)
CB069181 Pancreas, Purified pancreatic islet .a 3500 to 4002 503 to 1       503/503
(100 %)
0 diff
(100 %id)
DB376066 placenta .a 3515 to 4001 492 to 1       492/523
(94 %)
37 diff
(93.0 %id)
AL700615 human skeletal muscle .a 3528 to 4155 1 to 628       628/628
(100 %)
2 diff
(99.7 %id)
AI240596 pooled .a 3542 to 4004 463 to 1       463/463
(100 %)
0 diff
(100 %id)
AA742366 germinal center B cell .a 3544 to 3968 427 to 3       425/427
(99 %)
0 diff
(100 %id)
AA972891 pooled .a 3546 to 3961 416 to 1       416/416
(100 %)
0 diff
(100 %id)
AW770441 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .a 3561 to 3716 156 to 1       156/156
(100 %)
0 diff
(100 %id)
DB221465 trachea .a 3564 to 4110 2 to 548   capped   547/547
(100 %)
2 diff
(99.7 %id)
AL599358   .a 3609 to 4085 1 to 477       477/477
(100 %)
2 diff
(99.6 %id)
DA545941   .a 3637 to 4111 2 to 478   capped   477/477
(100 %)
5 diff
(99.0 %id)
BF431663 Kidney .a 3640 to 3961 333 to 12   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 322/322
(100 %)
0 diff
(100 %id)
AA578562 lung, lung tumor .a 3642 to 4003 362 to 1       362/362
(100 %)
0 diff
(100 %id)
AA280738 germinal center B cell .a 3676 to 4091 417 to 1       417/417
(100 %)
1 diff
(99.8 %id)
BG223302 normal squamous epithelium, tongue .a 3693 to 3961 322 to 54   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 269/275
(97 %)
1 diff
(99.7 %id)
AL701056 human skeletal muscle .a 3718 to 4528 1 to 820       820/838
(97 %)
17 diff
(98.0 %id)
DA239176 brain .a 3741 to 4315 2 to 577   capped   576/576
(100 %)
2 diff
(99.7 %id)
AA665027 alveolar rhabdomyosarcoma .a 3778 to 4008 231 to 1       231/236
(97 %)
1 diff
(99.6 %id)
AW449085   .a 3780 to 4003 239 to 16   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 224/234
(95 %)
0 diff
(100 %id)
AW572357 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 3787 to 4003 217 to 1       217/217
(100 %)
0 diff
(100 %id)
BE465244 Kidney .a 3813 to 4003 191 to 1       191/191
(100 %)
0 diff
(100 %id)
AA748357 germinal center B cell .a 3818 to 3968 153 to 3       151/153
(98 %)
0 diff
(100 %id)
FN048353 breast carcinoma .a 3827 to 3931 1 to 105       105/105
(100 %)
0 diff
(100 %id)
AL700420 human skeletal muscle .a 3882 to 4528 1 to 647   tiling clone,   647/649
(99 %)
2 diff
(99.7 %id)
DB358258 whole embryo, mainly head .a 3941 to 4514 568 to 1       568/571
(99 %)
18 diff
(96.9 %id)
BF516218   .a 4001 to 4514 531 to 18   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 514/514
(100 %)
2 diff
(99.7 %id)
AA459487 germinal center B cell .a 4003 to 4443 1 to 441       441/441
(100 %)
0 diff
(100 %id)
AI804003 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 4051 to 4513 463 to 1       463/463
(100 %)
0 diff
(100 %id)
AA612844 colon, colon tumor RER+ .a 4121 to 4513 393 to 1       393/393
(100 %)
0 diff
(100 %id)
BX489289   .a 4182 to 4852 1 to 685       685/692
(98 %)
7 diff
(99.0 %id)
AL705601 human skeletal muscle .a 4253 to 4632 37 to 429       393/429
(91 %)
6 diff
(98.7 %id)
DA327008 hippocampus .a 4337 to 4966 2 to 644   capped   643/643
(100 %)
6 diff
(99.1 %id)
CA393431 eye, RPE/choroid .a 4367 to 4683 1 to 330   tiling clone,   330/333
(99 %)
11 diff
(96.7 %id)
D60753   .a 4367 to 4679 1 to 324   tiling clone,   324/324
(100 %)
8 diff
(97.6 %id)
D81704 brain .a 4368 to 4722 1 to 368       368/368
(100 %)
7 diff
(98.1 %id)
BF795041 lymph, lymphoma, cell line .a 4405 to 5170 1 to 771       771/989
(77 %)
61 diff
(93.9 %id)
DA329093 hippocampus .a 4434 to 4900 2 to 482   tiling clone, capped   481/481
(100 %)
6 diff
(98.8 %id)
AL701074 human skeletal muscle .a 4459 to 5044 1 to 599       599/599
(100 %)
6 diff
(99.0 %id)
AA195537 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 4476 to 4915 1 to 455       455/455
(100 %)
7 diff
(98.5 %id)
BQ774886 Bone, Human Chondrosarcoma Cell Line .a 4546 to 5289 1 to 743   tiling clone, Submitted on the opposite strand 743/743
(100 %)
1 diff
(99.9 %id)
AI123797 pooled .a 4565 to 5146 1 to 582     Submitted on the opposite strand 582/582
(100 %)
0 diff
(100 %id)
BM724615 eye, fetal eye .a 4583 to 5139 1 to 558   fully sequenced,   558/558
(100 %)
3 diff
(99.5 %id)
CR738749 whole brain .a 4586 to 5217 1 to 632       632/632
(100 %)
0 diff
(100 %id)
AA488922 germinal center B cell .a 4591 to 5109 1 to 519       519/519
(100 %)
0 diff
(100 %id)
DB465883 hippocampus .a 4618 to 5034 1 to 417       417/417
(100 %)
0 diff
(100 %id)
DB469908 hippocampus .a 4618 to 5071 1 to 454       454/454
(100 %)
1 diff
(99.8 %id)
DA222715 brain .a 4649 to 5182 2 to 536   capped   535/535
(100 %)
1 diff
(99.9 %id)
BM560847 eye, retinoblastoma .a 4661 to 5051 1 to 394       394/1012
(38 %)
12 diff
(98.9 %id)
AV750774 Pituitary .a 4707 to 5138 1 to 418       418/418
(100 %)
10 diff
(97.7 %id)
AL700966 human skeletal muscle .a 4719 to 5310 1 to 592       592/592
(100 %)
1 diff
(99.9 %id)
BF940732 fibrotheoma, ovary .a 4723 to 5197 1 to 475     Submitted on the opposite strand 475/475
(100 %)
1 diff
(99.8 %id)
AA419347 germinal center B cell .a 4728 to 4914 1 to 187       187/187
(100 %)
1 diff
(99.5 %id)
AA262626 germinal center B cell .a 4754 to 4989 18 to 253       236/253
(93 %)
6 diff
(97.7 %id)
AA262401 germinal center B cell .a 4761 to 5215 1 to 455       455/455
(100 %)
0 diff
(100 %id)
AW968651   .a 4762 to 5291 1 to 531       531/531
(100 %)
7 diff
(98.7 %id)
AW968652   .a 4762 to 5204 1 to 443       443/443
(100 %)
13 diff
(97.1 %id)
AW968653   .a 4762 to 5380 1 to 619       619/619
(100 %)
5 diff
(99.2 %id)
AA406446 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 4762 to 5180 1 to 419       419/419
(100 %)
0 diff
(100 %id)
N36709 melanocyte .a 4763 to 4990 1 to 229       229/229
(100 %)
1 diff
(99.6 %id)
AA034295.
matches multiple genes
uterus .a 4763 to 4941 1 to 179     also hits gene ZNF559andZNF177 179/179
(100 %)
0 diff
(100 %id)
AA253015 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 4763 to 5194 1 to 432       432/432
(100 %)
0 diff
(100 %id)
AA279489 germinal center B cell .a 4788 to 4899 1 to 112       112/112
(100 %)
1 diff
(99.2 %id)
CR742313   .a 4790 to 5555 1 to 767       767/767
(100 %)
1 diff
(99.9 %id)
AA258496 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 4807 to 5239 8 to 440       433/441
(98 %)
3 diff
(99.4 %id)
N91646 liver and spleen .a 4826 to 5095 1 to 272       272/272
(100 %)
2 diff
(99.3 %id)
W79026 liver and spleen .a 4826 to 5259 1 to 436   fully sequenced,   436/436
(100 %)
3 diff
(99.4 %id)
DA104859 cerebellum .a 4828 to 5412 2 to 586   capped   585/585
(100 %)
1 diff
(99.9 %id)
BQ937988 leiomyosarcoma, uterus .a 4830 to 5712 1 to 890       890/892
(99 %)
16 diff
(98.3 %id)
N20616 melanocyte .a 4838 to 5051 1 to 214       214/214
(100 %)
3 diff
(98.6 %id)
BX507267 Liver .a 4889 to 5609 1 to 722       722/722
(100 %)
3 diff
(99.6 %id)
BX485159   .a 4913 to 5593 10 to 690       681/690
(98 %)
6 diff
(99.2 %id)
BX456481 thymus .a 4918 to 5372 600 to 1059       930/1059
(87 %)
32 diff
(97.0 %id)
R96589 liver and spleen .a 4942 to 5344 1 to 408       408/414
(98 %)
6 diff
(98.6 %id)
H59035 liver and spleen .a 4942 to 5336 1 to 405       405/405
(100 %)
14 diff
(96.6 %id)
TI_154102689   .a 4951 to 5706 833 to 86   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 748/800
(93 %)
13 diff
(98.4 %id)
CR742881   .a 4961 to 5605 1 to 645       645/645
(100 %)
0 diff
(100 %id)
FN055835 breast carcinoma .a 4961 to 5073 1 to 114       114/114
(100 %)
2 diff
(98.3 %id)
H59401 liver and spleen .a 4961 to 5254 1 to 300       300/312
(96 %)
10 diff
(96.8 %id)
CR736366 liver and spleen .a 4962 to 5706 1 to 744   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 744/744
(100 %)
3 diff
(99.6 %id)
R91659 liver and spleen .a 4962 to 5322 1 to 363       363/363
(100 %)
3 diff
(99.2 %id)
H61661 liver and spleen .a 4962 to 5418 1 to 461       461/461
(100 %)
11 diff
(97.7 %id)
W78956 liver and spleen .a 4962 to 5392 1 to 439   fully sequenced,   439/439
(100 %)
12 diff
(97.3 %id)
BU072138 Pancreas, Purified pancreatic islet .a 4965 to 5397 5 to 437   fully sequenced,   433/437
(99 %)
5 diff
(98.9 %id)
BM272019 Pancreas, Purified pancreatic islet .a 4971 to 5496 18 to 543       526/543
(96 %)
6 diff
(98.9 %id)
DA219518 brain .a 4973 to 5538 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DN949574 Pancreas, Purified pancreatic islet .a 4975 to 5340 1 to 366     Submitted on the opposite strand 366/366
(100 %)
0 diff
(100 %id)
CK824916 Pancreas, Purified pancreatic islet .a 5031 to 5180 1 to 150     Submitted on the opposite strand 150/150
(100 %)
1 diff
(99.4 %id)
FN082025 breast carcinoma .a 5035 to 5124 1 to 91       91/91
(100 %)
1 diff
(99.0 %id)
DA024662   .a 5038 to 5612 2 to 578   capped   577/577
(100 %)
2 diff
(99.7 %id)
W88972 liver and spleen .a 5055 to 5355 1 to 303   fully sequenced,   303/303
(100 %)
0 diff
(100 %id)
CB046330 2 pooled tumors (clear cell type), Kidney .a 5055 to 5741 10 to 696     Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 687/696
(98 %)
6 diff
(99.2 %id)
BX501221 Liver .a 5061 to 5733 1 to 673       673/673
(100 %)
2 diff
(99.8 %id)
N21026 melanocyte .a 5078 to 5705 630 to 1       630/630
(100 %)
23 diff
(96.4 %id)
R70964 placenta .a 5084 to 5590 1 to 504       504/505
(99 %)
14 diff
(97.3 %id)
BU741764 eye, fetal eye .a 5109 to 5723 614 to 1   fully sequenced,   614/614
(100 %)
4 diff
(99.4 %id)
CK824917 Pancreas, Purified pancreatic islet .a 5137 to 5720 588 to 5     Submitted on the opposite strand 584/588
(99 %)
0 diff
(100 %id)
AW967830   .a 5143 to 5705 562 to 1     Submitted on the opposite strand 562/566
(99 %)
13 diff
(97.8 %id)
AI935417 Kidney .a 5166 to 5706 541 to 1       541/541
(100 %)
1 diff
(99.9 %id)
CA445651 Chondrosarcoma, Left Pubic Bone .a 5168 to 5706 556 to 17   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 540/540
(100 %)
1 diff
(99.9 %id)
AI741992 pooled .a 5171 to 5705 535 to 1       535/535
(100 %)
2 diff
(99.7 %id)
BQ233228 leiomyosarcoma, uterus .a 5178 to 6203 1 to 1035       1035/1039
(99 %)
24 diff
(97.7 %id)
AW967828   .a 5181 to 5705 525 to 1     Submitted on the opposite strand 525/525
(100 %)
4 diff
(99.3 %id)
AI435856 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 5186 to 5705 520 to 1   tiling clone,   520/520
(100 %)
0 diff
(100 %id)
AA725895   .a 5199 to 5706 509 to 2       508/509
(99 %)
0 diff
(100 %id)
BF514662   .a 5212 to 5706 510 to 16   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 495/495
(100 %)
1 diff
(99.8 %id)
N53932 liver and spleen .a 5219 to 5706 488 to 1       488/489
(99 %)
1 diff
(99.8 %id)
DN949393.
matches multiple genes
Pancreas, Purified pancreatic islet .a 5219 to 5712 500 to 7   fully sequenced, Submitted on the opposite strand, also hits gene B4GALT1 494/500
(98 %)
0 diff
(100 %id)
AI248795 liver and spleen .a 5220 to 5706 487 to 1       487/487
(100 %)
1 diff
(99.8 %id)
AI743694 pooled .a 5220 to 5708 489 to 1       489/489
(100 %)
2 diff
(99.6 %id)
W80418 liver and spleen .a 5229 to 5706 479 to 1   fully sequenced,   479/479
(100 %)
2 diff
(99.6 %id)
AA581874 germ cell tumor .a 5229 to 5706 479 to 1       479/479
(100 %)
3 diff
(99.4 %id)
AA194938 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 5239 to 5707 470 to 1       470/470
(100 %)
2 diff
(99.6 %id)
AI057447 liver and spleen .a 5239 to 5706 468 to 1       468/468
(100 %)
1 diff
(99.8 %id)
BM271702 Pancreas, Purified pancreatic islet .a 5241 to 5706 467 to 1       467/467
(100 %)
3 diff
(99.4 %id)
AA701482 liver and spleen .a 5246 to 5706 461 to 1       461/461
(100 %)
6 diff
(98.7 %id)
AA705427 liver and spleen .a 5246 to 5707 462 to 1       462/462
(100 %)
2 diff
(99.6 %id)
AA806186 germinal center B cell .a 5246 to 5712 470 to 4       467/470
(99 %)
0 diff
(100 %id)
AA808294 germinal center B cell .a 5246 to 5712 470 to 4       467/470
(99 %)
0 diff
(100 %id)
N32280 melanocyte .a 5251 to 5707 462 to 1       462/464
(99 %)
11 diff
(97.7 %id)
N54336 liver and spleen .a 5252 to 5706 455 to 1       455/455
(100 %)
1 diff
(99.8 %id)
AI753396 bone marrow stroma .a 5256 to 5706 465 to 14   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 452/452
(100 %)
2 diff
(99.6 %id)
AI192835 lung .a 5262 to 5707 446 to 1       446/446
(100 %)
0 diff
(100 %id)
AA485223 germinal center B cell .a 5264 to 5712 452 to 4       449/452
(99 %)
0 diff
(100 %id)
AA410401 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 5266 to 5705 440 to 1       440/440
(100 %)
1 diff
(99.8 %id)
AA700235 liver and spleen .a 5267 to 5705 439 to 1       439/439
(100 %)
5 diff
(98.9 %id)
AA258332 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 5268 to 5707 440 to 1       440/440
(100 %)
0 diff
(100 %id)
AI089098 pooled .a 5272 to 5705 434 to 1       434/434
(100 %)
1 diff
(99.8 %id)
BQ022006 placenta .a 5280 to 5706 442 to 16   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 427/427
(100 %)
3 diff
(99.3 %id)
AW967829   .a 5282 to 5705 425 to 1     Submitted on the opposite strand 425/425
(100 %)
3 diff
(99.3 %id)
AI417670 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 5300 to 5705 406 to 1       406/406
(100 %)
1 diff
(99.8 %id)
AA243614 germinal center B cell .a 5312 to 5706 395 to 1       395/395
(100 %)
0 diff
(100 %id)
W88973 liver and spleen .a 5325 to 5682 357 to 1   fully sequenced,   357/357
(100 %)
1 diff
(99.8 %id)
BX502424 Liver .a 5326 to 5840 1 to 520       520/520
(100 %)
7 diff
(98.7 %id)
AA676538 liver and spleen .a 5328 to 5706 379 to 1       379/379
(100 %)
1 diff
(99.8 %id)
AA488851 germinal center B cell .a 5344 to 5712 372 to 4       369/372
(99 %)
0 diff
(100 %id)
AI937703 anaplastic oligodendroglioma, brain .a 5349 to 5706 358 to 1       358/358
(100 %)
3 diff
(99.2 %id)
R96590 liver and spleen .a 5352 to 5672 321 to 1       321/321
(100 %)
3 diff
(99.1 %id)
BF592077 Kidney .a 5353 to 5706 354 to 1       354/355
(99 %)
10 diff
(97.2 %id)
AA599959 bone marrow stroma .a 5361 to 5658 298 to 1       298/298
(100 %)
1 diff
(99.7 %id)
W80450 liver and spleen .a 5362 to 5707 350 to 1   fully sequenced,   350/350
(100 %)
8 diff
(97.8 %id)
AA243594 germinal center B cell .a 5367 to 5706 340 to 1       340/340
(100 %)
0 diff
(100 %id)
BU076123 Pancreas, Purified pancreatic islet .a 5367 to 5705 339 to 1   fully sequenced,   339/339
(100 %)
1 diff
(99.8 %id)
BE218227 carcinoid, lung .a 5371 to 5708 338 to 1       338/338
(100 %)
1 diff
(99.8 %id)
AI350939 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 5372 to 5704 334 to 1       334/334
(100 %)
2 diff
(99.5 %id)
AI240751 liver and spleen .a 5375 to 5706 333 to 1       333/335
(99 %)
2 diff
(99.5 %id)
N24728 melanocyte .a 5379 to 5649 272 to 1       272/272
(100 %)
2 diff
(99.3 %id)
DB187567 liver, tumor tissue .a 5388 to 5963 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA400009 thalamus .a 5391 to 5963 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DB153172 thymus .a 5399 to 5974 2 to 577   capped   576/576
(100 %)
2 diff
(99.7 %id)
N68753 liver and spleen .a 5405 to 5706 302 to 1       302/302
(100 %)
7 diff
(97.7 %id)
AA253027 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 5424 to 5706 278 to 1       278/278
(100 %)
8 diff
(97.2 %id)
H60057 liver and spleen .a 5427 to 5707 288 to 7       282/291
(96 %)
0 diff
(100 %id)
EC527275 Prostate .a 5469 to 5577 1 to 106       106/106
(100 %)
5 diff
(95.3 %id)
BG176854 lymph, lymphoma, cell line .a 5469 to 6128 1 to 653       653/661
(98 %)
12 diff
(98.2 %id)
D60390   .a 5490 to 5706 213 to 1       213/213
(100 %)
5 diff
(97.7 %id)
H59036 liver and spleen .a 5544 to 5683 140 to 1       140/142
(98 %)
3 diff
(97.9 %id)
BX474488   .a 5548 to 6149 1 to 603   tiling clone,   603/603
(100 %)
3 diff
(99.6 %id)
DA861935 placenta .a 5595 to 6175 2 to 583   capped   582/583
(99 %)
3 diff
(99.5 %id)
BQ432044 melanotic melanoma, skin .a 5747 to 6562 1 to 822       822/902
(91 %)
17 diff
(98.2 %id)
AA487727   .a 5858 to 6297 1 to 440     Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 440/440
(100 %)
0 diff
(100 %id)
TI_154170555   .a 5893 to 6393 93 to 598       506/1068
(47 %)
22 diff
(98.0 %id)
CF140168 CNCAP(3)T-225 cell line, Prostate .a 5896 to 6347 11 to 463       453/463
(97 %)
6 diff
(98.8 %id)
DA782052 brain .a 6031 to 6586 2 to 557   tiling clone, capped   556/556
(100 %)
0 diff
(100 %id)
DA935859 Spleen .a 6036 to 6640 2 to 607   capped   606/606
(100 %)
2 diff
(99.7 %id)
BE175743 head_neck .a 6043 to 6543 502 to 2     Submitted on the opposite strand 501/508
(98 %)
0 diff
(100 %id)
BE175744 head_neck .a 6043 to 6543 511 to 11     Submitted on the opposite strand 501/526
(95 %)
0 diff
(100 %id)
BE175765 head_neck .a 6082 to 6543 471 to 10     Submitted on the opposite strand 462/472
(97 %)
0 diff
(100 %id)
AW977587   .a 6090 to 6565 477 to 1     Submitted on the opposite strand 477/478
(99 %)
13 diff
(97.3 %id)
BG180159 adenocarcinoma, cell line, Prostate .a 6107 to 6766 1 to 651       651/940
(69 %)
13 diff
(98.7 %id)
BG112400 Bone, osteosarcoma, cell line .a 6116 to 6698 1 to 588       588/1009
(58 %)
22 diff
(97.9 %id)
FN058564 breast carcinoma .a 6131 to 6234 104 to 1     Submitted on the opposite strand 104/104
(100 %)
0 diff
(100 %id)
AA809932 germinal center B cell .a 6187 to 6573 388 to 2       387/388
(99 %)
0 diff
(100 %id)
DA019402   .a 6197 to 6714 2 to 520   capped   519/519
(100 %)
1 diff
(99.9 %id)
BX479786   .a 6213 to 6743 1 to 531       531/531
(100 %)
1 diff
(99.9 %id)
BF978869 melanotic melanoma, high MDR, skin .a 6246 to 6940 1 to 686       686/899
(76 %)
24 diff
(97.4 %id)
BF132005 hypernephroma, Kidney .a 6258 to 6895 1 to 621       621/782
(79 %)
31 diff
(96.1 %id)
BF107149 placenta .a 6268 to 6558 181 to 470       290/470
(61 %)
6 diff
(98.8 %id)
CB163376 Liver .a 6319 to 6871 1 to 553   tiling clone,   553/553
(100 %)
1 diff
(99.9 %id)
AA634985 lung, lung carcinoma .a 6329 to 6750 1 to 422       422/422
(100 %)
0 diff
(100 %id)
BX505870   .a 6338 to 6962 1 to 626       626/626
(100 %)
2 diff
(99.7 %id)
BF672536 muscle (skeletal) .a 6338 to 7053 1 to 700       700/819
(85 %)
43 diff
(94.8 %id)
BG434607 placenta .a 6343 to 7135 1 to 785       785/786
(99 %)
35 diff
(95.6 %id)
BX497370 Liver .a 6351 to 7061 1 to 712       712/712
(100 %)
2 diff
(99.8 %id)
BG107937 Bone, osteosarcoma, cell line .a 6358 to 7003 13 to 665       653/665
(98 %)
6 diff
(99.1 %id)
DB248339 uterus .a 6361 to 6996 2 to 637   capped   636/636
(100 %)
2 diff
(99.7 %id)
BQ216607 large cell carcinoma, lung .a 6375 to 7033 1 to 659       659/883
(74 %)
26 diff
(97.1 %id)
AL692910   .a 6385 to 6902 1 to 518       518/518
(100 %)
2 diff
(99.7 %id)
BE931749 head_neck .a 6402 to 6858 468 to 14       455/468
(97 %)
0 diff
(100 %id)
DN913367   .a 6466 to 7156 30 to 711       682/720
(94 %)
6 diff
(99.2 %id)
AA682214 schizophrenic brain S-11 frontal lobe .a 6512 to 6998 1 to 488     Submitted on the opposite strand 488/490
(99 %)
11 diff
(97.8 %id)
BG484291 lung .a 6543 to 7240 1 to 688       688/688
(100 %)
14 diff
(98.0 %id)
DB166021 thyroid gland .a 6567 to 7370 2 to 816   capped   815/854
(95 %)
21 diff
(97.6 %id)
CN358124 embryonic stem cells, cell lines H1, H7, andH9 .a 6580 to 6951 1 to 372       372/372
(100 %)
1 diff
(99.8 %id)
TI_149294700   .a 6627 to 7426 882 to 83   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 800/998
(80 %)
3 diff
(99.7 %id)
DA167616 amygdala .a 6647 to 7208 2 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
BG573133 placenta .a 6680 to 7384 1 to 705       705/705
(100 %)
6 diff
(99.2 %id)
TI_154099719   .a 6706 to 7444 58 to 797     Submitted on the opposite strand 740/797
(92 %)
6 diff
(99.3 %id)
CA441170 Fibrosarcoma .a 6715 to 7237 1 to 523     Submitted on the opposite strand 523/523
(100 %)
4 diff
(99.3 %id)
BU683259 lung .a 6729 to 7426 716 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 698/705
(99 %)
1 diff
(99.9 %id)
AW973702   .a 6814 to 7425 613 to 1     Submitted on the opposite strand 613/614
(99 %)
12 diff
(98.1 %id)
N22621 cochlea, ear .a 6816 to 7427 627 to 1       627/634
(98 %)
11 diff
(98.3 %id)
DA363506 subthalamic nucleus .a 6829 to 7344 2 to 517   capped   516/516
(100 %)
2 diff
(99.7 %id)
CN358127 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 6861 to 7104 1 to 244       244/244
(100 %)
0 diff
(100 %id)
CB117965 brain .a 6866 to 7209 1 to 344       344/344
(100 %)
2 diff
(99.5 %id)
BU509579 leiomyosarcoma, uterus .a 6904 to 7683 1 to 790       790/909
(86 %)
19 diff
(98.0 %id)
AL135138 melanoma (MeWo cell line) .a 6912 to 7461 1 to 551       551/551
(100 %)
1 diff
(99.9 %id)
DA831360 placenta .a 6928 to 7584 2 to 659   capped   658/658
(100 %)
2 diff
(99.7 %id)
BF439343 pooled .a 6941 to 7428 492 to 5       488/492
(99 %)
0 diff
(100 %id)
AW150307 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 6945 to 7428 484 to 1       484/484
(100 %)
0 diff
(100 %id)
AI582237 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 6959 to 7426 468 to 1       468/468
(100 %)
1 diff
(99.8 %id)
C21445   .a 6970 to 7314 1 to 352       352/355
(99 %)
8 diff
(97.8 %id)
AA487510   .a 6979 to 7426 458 to 11   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 448/448
(100 %)
1 diff
(99.8 %id)
AA629814 lung, lung carcinoma .a 6985 to 7425 441 to 1       441/441
(100 %)
0 diff
(100 %id)
AW170648 bowel (skin primary), metastatic melanoma to bowel .a 6988 to 7428 445 to 5       441/445
(99 %)
0 diff
(100 %id)
AA828424 germinal center B cell .a 7005 to 7426 444 to 23   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 422/431
(97 %)
3 diff
(99.4 %id)
TI_57218453   .a 7113 to 7964 34 to 901       868/902
(96 %)
35 diff
(96.2 %id)
CR617658 HeLa cells Cot 25-normalized .a 7119 to 8753 1 to 1635   tiling clone,   1635/1635
(100 %)
0 diff
(100 %id)
BI754901 brain .a 7119 to 7964 1 to 863       863/864
(99 %)
33 diff
(96.2 %id)
EC525928 Prostate .a 7129 to 7229 1 to 97       97/97
(100 %)
5 diff
(94.9 %id)
D79418 aorta .a 7135 to 7426 1 to 292       292/292
(100 %)
1 diff
(99.7 %id)
D62745   .a 7139 to 7417 24 to 301   fully sequenced,   278/301
(92 %)
6 diff
(98.1 %id)
D62744   .a 7179 to 7426 248 to 1   fully sequenced,   248/248
(100 %)
0 diff
(100 %id)
EC475352 Prostate .a 7187 to 7298 110 to 1       110/112
(98 %)
7 diff
(93.8 %id)
BX350393   .a 7188 to 8060 872 to 1       872/872
(100 %)
9 diff
(99.0 %id)
EC490415 Prostate .a 7195 to 7305 108 to 1       108/108
(100 %)
3 diff
(97.3 %id)
AA554443 breast .a 7195 to 7425 231 to 1       231/231
(100 %)
0 diff
(100 %id)
DA568702 whole embryo, mainly head .a 7204 to 8018 2 to 818   capped   817/821
(99 %)
8 diff
(99.1 %id)
EC505937 Prostate .a 7230 to 7337 104 to 1       104/104
(100 %)
4 diff
(96.2 %id)
EC577442 Prostate .a 7232 to 7338 106 to 1       106/106
(100 %)
1 diff
(99.1 %id)
EC563839 Prostate .a 7233 to 7335 106 to 4       103/111
(92 %)
0 diff
(100 %id)
CB046329 2 pooled tumors (clear cell type), Kidney .a 7237 to 7426 216 to 27   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 190/190
(100 %)
0 diff
(100 %id)
BQ896018 eye, retinoblastoma .a 7239 to 7986 1 to 758       758/970
(78 %)
23 diff
(97.7 %id)
EC490020 Prostate .a 7265 to 7365 101 to 1       101/102
(99 %)
0 diff
(100 %id)
CN358125 embryonic stem cells, DMSO-treated H9 cellline .a 7274 to 8014 9 to 747       739/747
(98 %)
6 diff
(99.2 %id)
EC464796 Prostate .a 7285 to 7371 94 to 8       87/94
(92 %)
0 diff
(100 %id)
EC486055 Prostate .a 7285 to 7372 87 to 1       87/87
(100 %)
1 diff
(98.9 %id)
EC507557 Prostate .a 7285 to 7373 92 to 4       89/92
(96 %)
0 diff
(100 %id)
EC522320 Prostate .a 7285 to 7374 91 to 2       90/91
(98 %)
0 diff
(100 %id)
EC580099 Prostate .a 7285 to 7371 93 to 7       87/93
(93 %)
0 diff
(100 %id)
EC555321 Prostate .a 7287 to 7378 95 to 5       91/95
(95 %)
0 diff
(100 %id)
EC569325 Prostate .a 7287 to 7381 94 to 2       93/94
(98 %)
0 diff
(100 %id)
EC583384 Prostate .a 7287 to 7381 93 to 1       93/93
(100 %)
2 diff
(97.9 %id)
EC461342 Prostate .a 7299 to 7395 97 to 1       97/97
(100 %)
0 diff
(100 %id)
EC489848 Prostate .a 7299 to 7395 97 to 1       97/97
(100 %)
0 diff
(100 %id)
CN358126 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 7307 to 7977 1 to 671       671/671
(100 %)
4 diff
(99.5 %id)
EC456395 Prostate .a 7314 to 7418 104 to 1       104/104
(100 %)
1 diff
(99.1 %id)
EC572642 Prostate .a 7314 to 7418 104 to 2       103/104
(99 %)
0 diff
(100 %id)
EC440617 Prostate .a 7316 to 7416 116 to 15       102/116
(87 %)
0 diff
(100 %id)
EC452729 Prostate .a 7316 to 7428 118 to 6       113/118
(95 %)
0 diff
(100 %id)
EC454404 Prostate .a 7316 to 7426 112 to 2       111/112
(99 %)
0 diff
(100 %id)
EC455735 Prostate .a 7316 to 7426 110 to 2       109/110
(99 %)
0 diff
(100 %id)
EC457376 Prostate .a 7316 to 7426 109 to 2       108/109
(99 %)
0 diff
(100 %id)
EC457448 Prostate .a 7316 to 7416 115 to 15       101/115
(87 %)
0 diff
(100 %id)
EC470816 Prostate .a 7316 to 7422 112 to 7       106/112
(94 %)
0 diff
(100 %id)
EC472027 Prostate .a 7316 to 7428 118 to 6       113/118
(95 %)
0 diff
(100 %id)
EC473510 Prostate .a 7316 to 7422 114 to 7       108/114
(94 %)
0 diff
(100 %id)
EC487883 Prostate .a 7316 to 7428 115 to 2       114/115
(99 %)
0 diff
(100 %id)
EC498812 Prostate .a 7316 to 7428 113 to 1       113/113
(100 %)
0 diff
(100 %id)
EC500104 Prostate .a 7316 to 7414 116 to 19       98/116
(84 %)
0 diff
(100 %id)
EC516483 Prostate .a 7316 to 7428 115 to 2       114/115
(99 %)
0 diff
(100 %id)
EC522668 Prostate .a 7316 to 7428 119 to 8       112/119
(94 %)
0 diff
(100 %id)
EC538378 Prostate .a 7316 to 7428 117 to 7       111/117
(94 %)
0 diff
(100 %id)
EC554084 Prostate .a 7316 to 7428 111 to 1       111/111
(100 %)
3 diff
(97.3 %id)
EC557479 Prostate .a 7316 to 7415 117 to 17       101/117
(86 %)
0 diff
(100 %id)
EC567881 Prostate .a 7316 to 7426 121 to 12   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 110/110
(100 %)
1 diff
(99.1 %id)
EC569449 Prostate .a 7316 to 7428 109 to 3       107/109
(98 %)
0 diff
(100 %id)
EC571673 Prostate .a 7316 to 7415 114 to 17       98/114
(85 %)
0 diff
(100 %id)
EC577484 Prostate .a 7316 to 7428 112 to 2       111/112
(99 %)
0 diff
(100 %id)
EC579595 Prostate .a 7316 to 7428 114 to 4       111/114
(97 %)
0 diff
(100 %id)
EC581948 Prostate .a 7316 to 7428 116 to 6       111/116
(95 %)
0 diff
(100 %id)
EC570664 Prostate .a 7317 to 7426 108 to 1       108/111
(97 %)
2 diff
(98.2 %id)
BF102503 adenocarcinoma, Prostate .a 7346 to 7973 1 to 629       629/632
(99 %)
5 diff
(99.3 %id)
EC449948 Prostate .a 7357 to 7465 109 to 1       109/109
(100 %)
0 diff
(100 %id)
BM015326 breast, mammary adenocarcinoma, cell line .a 7376 to 7934 1 to 556       556/557
(99 %)
12 diff
(97.9 %id)
TI_59393556   .a 7376 to 7934 48 to 603       556/557
(99 %)
12 diff
(97.9 %id)
BG023965 duodenal adenocarcinoma, cell line, small intestine .a 7388 to 8111 17 to 742       726/1050
(69 %)
23 diff
(97.9 %id)
BF102536 adenocarcinoma, Prostate .a 7400 to 8101 1 to 695       695/790
(87 %)
25 diff
(96.9 %id)
DR422624 eye, Pterygium .a 7462 to 8133 1 to 672       672/672
(100 %)
0 diff
(100 %id)
W37943 parathyroid gland, parathyroid tumor .a 7495 to 8086 1 to 599       599/600
(99 %)
12 diff
(98.0 %id)
BF027905 bladder, carcinoma, cell line .a 7495 to 8170 1 to 654       654/858
(76 %)
22 diff
(97.5 %id)
BE179869 head_neck .a 7521 to 7967 468 to 23     Submitted on the opposite strand 446/468
(95 %)
0 diff
(100 %id)
BF217331 brain, glioblastoma .a 7526 to 8139 1 to 608       608/822
(73 %)
16 diff
(98.1 %id)
AA328415   .a 7564 to 7843 1 to 280       280/288
(97 %)
1 diff
(99.7 %id)
AA319666 adrenal gland .a 7572 to 7881 1 to 311       311/314
(99 %)
3 diff
(99.1 %id)
AW964506   .a 7573 to 8250 1 to 674       674/714
(94 %)
13 diff
(98.2 %id)
BG776563 lung, mucoepidermoid carcinoma .a 7611 to 8324 1 to 717       717/777
(92 %)
11 diff
(98.6 %id)
BG402930 bladder, transitional cell papilloma, cell line .a 7612 to 8391 1 to 771       771/771
(100 %)
9 diff
(98.9 %id)
BG289027 bladder, transitional cell papilloma, cell line .a 7649 to 8331 30 to 714       685/916
(74 %)
17 diff
(98.2 %id)
CN358128 embryonic stem cells, DMSO-treated H9 cellline .a 7702 to 8324 8 to 631       624/631
(98 %)
7 diff
(98.9 %id)
BP422447 small intestine .a 7707 to 8226 1 to 521     Submitted on the opposite strand 521/521
(100 %)
3 diff
(99.5 %id)
BG025907 Bone, osteosarcoma, cell line .a 7740 to 8478 1 to 731       731/951
(76 %)
16 diff
(98.4 %id)
BG541237 lung .a 7750 to 8357 1 to 610       610/882
(69 %)
10 diff
(98.9 %id)
CB998434 Blood vessels - aorta, basilar and artery .a 7752 to 8464 1 to 719       719/727
(98 %)
11 diff
(98.5 %id)
CD643394 Embryonic Stem cells .a 7776 to 8523 1 to 746       746/823
(90 %)
8 diff
(99.1 %id)
TI_149296381   .a 7813 to 8658 899 to 78   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 822/931
(88 %)
27 diff
(97.1 %id)
CN291920 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 7838 to 8587 9 to 757       749/757
(98 %)
7 diff
(99.1 %id)
BX330973   .a 7870 to 8779 906 to 1       906/906
(100 %)
9 diff
(99.1 %id)
BM720068 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 7882 to 8329 1 to 448   fully sequenced, Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 448/448
(100 %)
3 diff
(99.4 %id)
DB377000 placenta .a 8077 to 8658 577 to 1       577/581
(99 %)
18 diff
(97.0 %id)
DB355247 whole embryo, mainly head .a 8216 to 8780 564 to 1       564/565
(99 %)
11 diff
(98.1 %id)
DB381930 thyroid gland .a 8228 to 8782 548 to 1   tiling clone,   548/548
(100 %)
7 diff
(98.8 %id)
W37881 parathyroid gland, parathyroid tumor .a 8252 to 8784 537 to 3       535/545
(98 %)
0 diff
(100 %id)
BU739884 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 8299 to 8778 497 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 479/479
(100 %)
2 diff
(99.6 %id)
DB068916 testis .b -24809 to -24533 2 to 278   capped   277/277
(100 %)
0 diff
(100 %id)
BG470848 eye, retinoblastoma .b 1 to 473 1 to 473   tiling clone, available from MGC,   473/717
(65 %)
1 diff
(99.9 %id)
BC033115 Eye, retinoblastoma .b 2 to 3287 1 to 3286 exact AAA   3286/4090
(80 %)
3 diff
(100.0 %id)
BC014186 Eye, retinoblastoma .b 2 to 3287 1 to 3286 exact tiling clone, available from MGC, AAA   3286/4090
(80 %)
3 diff
(100.0 %id)
BE255862 eye, retinoblastoma .b 21 to 653 1 to 634       634/722
(87 %)
9 diff
(98.8 %id)
BQ439840 embryonal carcinoma, cell line, testis .b 895 to 1785 1 to 898       898/898
(100 %)
14 diff
(98.5 %id)
CF143828 lymph .b 958 to 1369 1 to 412       412/414
(99 %)
5 diff
(98.8 %id)
CF144029 lymph .b 958 to 1351 1 to 393       393/393
(100 %)
3 diff
(99.3 %id)
TI_154175448   .b 966 to 1390 80 to 505       426/427
(99 %)
3 diff
(99.3 %id)
TI_154175834   .b 966 to 1370 80 to 484       405/406
(99 %)
1 diff
(99.8 %id)
AL703586 human skeletal muscle .b 1504 to 2091 1 to 589       589/589
(100 %)
1 diff
(99.9 %id)
DA483138 brain .b 1547 to 2316 2 to 775   capped   774/846
(91 %)
7 diff
(99.2 %id)
EH340309   .b 1593 to 1677 1 to 85       85/86
(98 %)
2 diff
(97.7 %id)
BG545518 lung .b 1603 to 2191 1 to 600   available from MGC,   583/847
(68 %)
28 diff
(96.7 %id)
DB219388 trachea .b 1622 to 2180 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
CR981784 T-Lymphocytes .b 1643 to 2414 1 to 772       772/772
(100 %)
0 diff
(100 %id)
CD685731 normal nasopharynx .b 1840 to 2464 15 to 639       625/639
(97 %)
7 diff
(99.0 %id)
BU192771 eye, retinoblastoma .b 1872 to 2744 1 to 883       883/884
(99 %)
10 diff
(98.9 %id)
BF825333 head_normal .b 2085 to 2554 474 to 5     Submitted on the opposite strand 470/474
(99 %)
1 diff
(99.8 %id)
BE882217 leiomyosarcoma, uterus .b 2128 to 2763 1 to 653       653/696
(93 %)
30 diff
(95.7 %id)
BM552694 astrocytoma grade IV, cell line, brain .b 2141 to 3003 1 to 876       876/1031
(84 %)
25 diff
(97.6 %id)
BU178571 eye, retinoblastoma .b 2141 to 2972 12 to 849       838/859
(97 %)
16 diff
(98.2 %id)
BM910672 astrocytoma grade IV, cell line, brain .b 2142 to 2641 1 to 498   AAA   499/1165
(42 %)
15 diff
(98.8 %id)
DA857858 placenta .b 2285 to 2835 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
BE296548 muscle, rhabdomyosarcoma .b 2438 to 2931 1 to 494       494/494
(100 %)
0 diff
(100 %id)
DA568512 whole embryo, mainly head .b 2450 to 3209 2 to 757   capped   756/758
(99 %)
11 diff
(98.6 %id)
AW182249 pooled .b 2471 to 2733 264 to 1       264/264
(100 %)
6 diff
(97.8 %id)
DB339976 testis .b 2635 to 3171 537 to 1       537/537
(100 %)
7 diff
(98.7 %id)
BF086114 placenta_normal .b 2901 to 3064 12 to 174       163/174
(93 %)
6 diff
(96.6 %id)
FN060598 breast carcinoma .b 3116 to 3245 129 to 1     Submitted on the opposite strand 129/129
(100 %)
1 diff
(99.3 %id)
DA786473 brain .c 1 to 575 2 to 576   tiling clone, capped   575/575
(100 %)
0 diff
(100 %id)
DB326431 brain .c 2304 to 2847 544 to 1   tiling clone,   544/544
(100 %)
0 diff
(100 %id)
DA484581 brain .d 1 to 556 2 to 557   tiling clone, capped   556/556
(100 %)
0 diff
(100 %id)
DB315118 brain .d 2121 to 2658 539 to 1   tiling clone,   539/539
(100 %)
1 diff
(99.9 %id)
DA933119 Spleen .e 1 to 543 2 to 544 exact tiling clone, capped   543/543
(100 %)
0 diff
(100 %id)
BM930378 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 1 to 305 269 to 573 L2Q L4A tiling clone,   305/573
(53 %)
11 diff
(98.1 %id)
BQ187522 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 1 to 299 269 to 567       299/567
(52 %)
7 diff
(98.8 %id)
AI904584 breast .g 1 to 283 293 to -1 Q7P D8G A9C K10Q G12R ... tiling clone,   290/293
(98 %)
3 diff
(99.0 %id)
DA356776 subthalamic nucleus .h-u 1 to 582 2 to 582   tiling clone, capped   581/581
(100 %)
5 diff
(99.2 %id)
BE783763 eye, retinoblastoma .h-u 11 to 760 1 to 736       736/794
(92 %)
26 diff
(96.8 %id)
BE909099 epithelioid carcinoma, Pancreas .h-u 16 to 745 735 to 1     Submitted on the opposite strand 735/867
(84 %)
22 diff
(97.5 %id)
BF434876 Kidney .h-u 87 to 625 541 to 4   tiling clone,   538/541
(99 %)
0 diff
(100 %id)
FN051970 breast carcinoma .h-u 105 to 204 1 to 100       100/101
(99 %)
1 diff
(99.1 %id)
AA496771   .h-u 107 to 448 1 to 342       342/342
(100 %)
2 diff
(99.5 %id)
D61559   .h-u 108 to 468 1 to 362       362/362
(100 %)
2 diff
(99.5 %id)
D61642   .h-u 108 to 424 1 to 316       316/318
(99 %)
5 diff
(98.5 %id)
TI_149290673   .h-u 111 to 881 857 to 96   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 762/931
(81 %)
18 diff
(98.1 %id)
AI765024 Kidney .h-u 112 to 625 514 to 2       513/514
(99 %)
0 diff
(100 %id)
BQ574306 Chondrosarcoma Grade II, Left Pelvis .h-u 126 to 761 653 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 635/639
(99 %)
4 diff
(99.4 %id)
BU684341 lung, Primary Lung Cystic Fibrosis EpithelialCells .h-u 159 to 761 617 to 17   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 601/601
(100 %)
2 diff
(99.7 %id)
AI277734 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h-u 175 to 625 450 to 1       450/450
(100 %)
1 diff
(99.8 %id)
TI_154010312   .h-u 175 to 883 814 to 104   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 711/1156
(61 %)
23 diff
(98.1 %id)
AW165992 brain, medulloblastoma .h-u 189 to 762 578 to 5       574/578
(99 %)
0 diff
(100 %id)
CB127499 cervix, Uterine .h-u 190 to 545 1 to 357       357/357
(100 %)
1 diff
(99.8 %id)
BM829656 stomach .h-u 208 to 738 1 to 531       531/531
(100 %)
25 diff
(95.3 %id)
AW243097 Kidney .h-u 226 to 761 535 to 1       535/535
(100 %)
2 diff
(99.7 %id)
AI590668 normal gingiva (cell line from immortalizedkeratinocytes) .h-u 228 to 624 397 to 2       396/397
(99 %)
0 diff
(100 %id)
BQ016657 lung, Metastatic Chondrosarcoma .h-u 245 to 881 655 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 637/637
(100 %)
5 diff
(99.3 %id)
BG777620 adenocarcinoma, Prostate .h-u 297 to 983 1 to 685 F8L N37*     685/685
(100 %)
18 diff
(97.4 %id)
AI264662 Kidney .h-u 300 to 762 463 to 2       462/470
(98 %)
0 diff
(100 %id)
FN165368 breast carcinoma .h-u 305 to 415 111 to 1     Submitted on the opposite strand 111/111
(100 %)
3 diff
(97.3 %id)
AI376934   .h-u 309 to 762 461 to 7       455/461
(98 %)
0 diff
(100 %id)
BM905967 leiomyosarcoma, uterus .h-u 317 to 1259 11 to 974 exact     964/977
(98 %)
36 diff
(96.4 %id)
BF510317   .h-u 321 to 761 457 to 18   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 440/455
(96 %)
3 diff
(99.4 %id)
BF509673   .h-u 321 to 761 457 to 18   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 440/449
(97 %)
4 diff
(99.2 %id)
BF508497   .h-u 327 to 761 451 to 18   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 434/434
(100 %)
3 diff
(99.4 %id)
AI022586 parathyroid gland, parathyroid tumor .h-u 343 to 761 418 to 1       418/418
(100 %)
1 diff
(99.8 %id)
AA377460 synovial membrane .h-u 348 to 606 1 to 258       258/260
(99 %)
2 diff
(99.3 %id)
AW963946   .h-u 349 to 750 1 to 401       401/548
(73 %)
2 diff
(99.7 %id)
CA435555 lung, Metastatic Chondrosarcoma .h-u 349 to 883 550 to 17   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 534/534
(100 %)
1 diff
(99.9 %id)
BF197558 Kidney .h-u 351 to 881 530 to 1       530/530
(100 %)
3 diff
(99.5 %id)
AI636171 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .h-u 397 to 887 492 to 2       491/492
(99 %)
0 diff
(100 %id)
AI888415 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .h-u 403 to 762 361 to 3       359/361
(99 %)
0 diff
(100 %id)
FN139329 breast carcinoma .h-u 426 to 503 77 to 1     Submitted on the opposite strand 77/77
(100 %)
1 diff
(98.8 %id)
BE967428 brain .h-u 429 to 672 1 to 243       243/358
(67 %)
5 diff
(98.7 %id)
BE673314 Prostate .h-u 432 to 881 449 to 1       449/449
(100 %)
3 diff
(99.4 %id)
DB532796 hippocampus .h-u 439 to 881 1 to 443     Submitted on the opposite strand 443/443
(100 %)
3 diff
(99.4 %id)
BQ029540 lung, Metastatic Chondrosarcoma .h-u 439 to 881 460 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 442/442
(100 %)
1 diff
(99.8 %id)
AA496714   .h-u 442 to 882 442 to 3       440/442
(99 %)
0 diff
(100 %id)
AA425367   .h-u 444 to 887 446 to 4       443/446
(99 %)
0 diff
(100 %id)
DB537677 hippocampus .h-u 454 to 881 1 to 427     Submitted on the opposite strand 427/427
(100 %)
9 diff
(97.9 %id)
BE350218 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .h-u 464 to 887 426 to 4       423/426
(99 %)
0 diff
(100 %id)
AI050053   .h-u 478 to 884 407 to 2   tiling clone,   406/407
(99 %)
0 diff
(100 %id)
AI658564 Prostate .h-u 528 to 887 365 to 6       360/365
(98 %)
0 diff
(100 %id)
AA844223 parathyroid gland, parathyroid tumor .h-u 537 to 887 353 to 3       351/353
(99 %)
0 diff
(100 %id)
AA774761 schizophrenic brain S-11 frontal lobe .h-u 543 to 874 332 to 1       332/332
(100 %)
0 diff
(100 %id)
BF574979 muscle (skeletal) .h-u 564 to 1211 1 to 631 F8L V9L E11N C12A L13*     631/706
(89 %)
27 diff
(96.2 %id)
R74382 placenta .h-u 654 to 1098 1 to 438 exact     438/438
(100 %)
16 diff
(96.4 %id)
R74394 placenta .h-u 654 to 1031 1 to 377 exact     377/380
(99 %)
4 diff
(99.0 %id)
AI813407 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .h-u 665 to 881 217 to 1       217/217
(100 %)
3 diff
(98.7 %id)
AA528739 alveolar rhabdomyosarcoma .h-u 672 to 883 213 to 1       213/218
(97 %)
3 diff
(98.7 %id)
FN172711 breast carcinoma .h-u 687 to 793 105 to 1     Submitted on the opposite strand 105/108
(97 %)
6 diff
(94.5 %id)
H24509.
matches multiple genes
breast .h-u 693 to 841 153 to 1     Submitted on the opposite strand, also hits gene ACAD8 153/153
(100 %)
4 diff
(97.4 %id)
AA090951   .h-u 739 to 917 1 to 177 I2T L19*     177/179
(98 %)
7 diff
(96.1 %id)
CD250687 Blood vessels - aorta, basilar and artery .h-u 817 to 1514 1 to 712   tiling clone,   712/761
(93 %)
31 diff
(96.0 %id)
W76005 heart .h-u 819 to 1266 1 to 455   tiling clone,   455/455
(100 %)
9 diff
(98.1 %id)
BQ574019 Chondrosarcoma Grade II, Left Pelvis .h-u 913 to 1661 767 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 749/753
(99 %)
3 diff
(99.7 %id)
H89226 cochlea, ear .h-u 990 to 1289 1 to 309   fully sequenced,   309/309
(100 %)
12 diff
(96.2 %id)
AA215347 germinal center B cell .h-u 997 to 1171 1 to 175       175/178
(98 %)
2 diff
(98.9 %id)
BE048628 Kidney .h-u 1070 to 1663 594 to 1   tiling clone,   594/597
(99 %)
0 diff
(100 %id)
DN913366   .h-u 1081 to 1660 583 to 4       580/583
(99 %)
0 diff
(100 %id)
AW978036   .h-u 1124 to 1660 538 to 1     Submitted on the opposite strand 538/538
(100 %)
6 diff
(98.9 %id)
BE220433 carcinoid, lung .h-u 1178 to 1669 495 to 4   tiling clone,   492/495
(99 %)
0 diff
(100 %id)
AI263115 Kidney .h-u 1207 to 1661 455 to 1       455/455
(100 %)
0 diff
(100 %id)
AA804203 germinal center B cell .h-u 1231 to 1661 442 to 12   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 431/431
(100 %)
0 diff
(100 %id)
R74383 placenta .h-u 1244 to 1627 387 to 1       387/387
(100 %)
11 diff
(97.2 %id)
H89119 cochlea, ear .h-u 1259 to 1644 388 to 1   fully sequenced,   388/388
(100 %)
5 diff
(98.8 %id)
AA935386 Kidney, kidney tumor .h-u 1294 to 1662 369 to 1       369/369
(100 %)
0 diff
(100 %id)
AI863550 Kidney .h-u 1321 to 1665 345 to 1       345/345
(100 %)
0 diff
(100 %id)
AW136240   .h-u 1323 to 1661 353 to 16   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 338/338
(100 %)
3 diff
(99.2 %id)
AW074480 colon, juvenile granulosa tumor .h-u 1324 to 1661 340 to 1       340/340
(100 %)
2 diff
(99.5 %id)
AI275750 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .h-u 1351 to 1662 312 to 1       312/312
(100 %)
0 diff
(100 %id)
BE882388 leiomyosarcoma, uterus .h-u 1378 to 1656 1 to 279       279/279
(100 %)
6 diff
(97.9 %id)
R74395 placenta .h-u 1382 to 1640 259 to 1       259/259
(100 %)
0 diff
(100 %id)
T48224 fetal spleen, Spleen .h-u 1410 to 1665 1 to 256   fully sequenced,   256/256
(100 %)
4 diff
(98.5 %id)
T48225 fetal spleen, Spleen .h-u 1499 to 1661 162 to 1   fully sequenced,   162/162
(100 %)
1 diff
(99.4 %id)
AA215348 germinal center B cell .h-u 1549 to 1663 115 to 1       115/115
(100 %)
0 diff
(100 %id)
CN288454 embryonic stem cells, DMSO-treated H9 cellline .i-u 1 to 698 1 to 698 exact tiling clone,   698/698
(100 %)
0 diff
(100 %id)
BQ380532 uterus_tumor .i-u 574 to 1002 429 to 2       428/447
(95 %)
0 diff
(100 %id)
AA476783   .i-u 677 to 1151 475 to 1   tiling clone,   475/475
(100 %)
0 diff
(100 %id)
AA476773   .i-u 762 to 1150 389 to 1       389/389
(100 %)
0 diff
(100 %id)
R66624 placenta .j-u 1 to 516 1 to 518   tiling clone,   518/519
(99 %)
9 diff
(98.3 %id)
H78860 liver and spleen .j-u 4 to 341 1 to 340       340/349
(97 %)
3 diff
(99.2 %id)
H58990 liver and spleen .j-u 66 to 437 1 to 376   tiling clone,   376/455
(82 %)
5 diff
(99.0 %id)
BX115813 liver and spleen .j-u 583 to 1111 1 to 529 exact tiling clone, AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 529/529
(100 %)
2 diff
(99.7 %id)
H80487 liver and spleen .j-u 583 to 952 1 to 372 exact tiling clone, fully sequenced,   372/372
(100 %)
2 diff
(99.5 %id)
AI798164 pooled .j-u 636 to 1106 484 to 14   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 471/471
(100 %)
1 diff
(99.8 %id)
AI591323 brain, tumor, 5 pooled (see description) .j-u 745 to 1111 368 to 2       367/368
(99 %)
0 diff
(100 %id)
H58943 liver and spleen .j-u 757 to 1105 350 to 1       350/350
(100 %)
9 diff
(97.5 %id)
H80104 liver and spleen .j-u 809 to 1110 301 to 1       301/301
(100 %)
4 diff
(98.7 %id)
H81404 liver and spleen .j-u 922 to 1118 197 to 1   fully sequenced,   197/197
(100 %)
1 diff
(99.5 %id)
BE172157 head_neck Gene MIB1, variant not shown              
BX362653   Gene MIB1, variant not shown              
AV727020 hypothalamus Gene MIB1, variant not shown         Suspected internal deletion, this clone was ignored    
H58226 liver and spleen Gene MIB1, variant not shown         This clone was ignored    
H58563 liver and spleen Gene MIB1, variant not shown         This clone was ignored    
BF439423 pooled Gene MIB1, variant not shown         Suspected internal deletion, this clone was ignored    
BM973640 lung Gene MIB1, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u, .i-u, .j-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI